HIV PrEP

Science Times - HIV Prevention: FDA Announces Approval of Apretude, the First Injectable Drug That Does Not Require Daily Dosage

HIV Prevention: Apretude, the First Injectable Drug That Can Replace Daily Pill Now FDA Approved

Medicine & Technology Dec 23, 2021

The FDA announced its approval of the first injectable human immunodeficiency virus (HIV) prevention treatment called Apretude for use in at-risk individuals both adults and children.

HIV PrEP

HIV Prevention: Apretude, the First Injectable Drug That Can Replace Daily Pill Now FDA Approved

Most Popular

Anavex Life Sciences Alzheimer's Treatment Brings Hope to Millions

Cave of Death in Costa Rica Appears Harmless but Can Instantly Kill Anyone at the Entrance

Should You Shower Everyday? Here's What Happens If You Shower Too Much, Too Little

The AI Revolution in Investment Management

Project Hephaistos: Scientists Claim To Have Detected Technosignatures From Dyson Spheres of Alien Civilization

Recommended Stories

SpaceX’s Starship Megarocket Prepares for Next Test Flight in 3–5 Weeks, Confirms Elon Musk

NASA’s James Webb Shares High-Definition Photos of Horsehead Nebula With Its Billowing ‘Mane’

Manganese-Rich Sandstones Indicate Earth-Like Environment Likely Existed on Ancient Mars

NASA's Juno Mission Releases New Photos Featuring Great Red Spot, Potato-Like Shape Moon Amalthea